Congress Poster Awards

Posted on by Soto Ella

Presented for Best Congress TDM and Best Congress CT Poster Presentations

The awards shall be presented to the author or group of authors of each of two posters presented at the IATDMCT Congress.

  • One poster will be selected as the Best Poster in the field of Clinical Toxicology.
  • One poster will be selected as the Best Poster in the field of Therapeutic Drug Monitoring.

Terms of Reference

The awards shall be presented to the author or group of authors of each of two posters presented at the IATDMCT Congress.

  • One poster will be selected as the Best Poster in the field of Clinical Toxicology and the other will be the Best Poster in the field of Therapeutic Drug Monitoring.
  • The posters selected for these awards shall be determined by an independent panel of judges.
  • The panel of judges will include the person from the Congress Organizing Committee who is responsible for abstracts (or their designates from the Organizing Committee), the Editors-in-Chief of Therapeutic Drug Monitoring (or their designate from the Editorial Board), and an IATDMCT Director of Education. The Editors-in-Chief of TDM (or their designates) will co-chair the panel. At their discretion, these judges can appoint additional judges as required.
  • A poster is eligible if at least one author is an IATDMCT member and none of the authors is a member of the panel of judges. If a judge works in the same laboratory as one of the authors, the judge must remove himself from the adjudication of that poster.
  • Each Award will consist of a certificate for the first author. The Awards will be presented at the Closing Ceremony or at some other suitable occasion during the conference.
  • The marking scheme for posters will be
    • Originality (40%),
    • Significance (20%),
    • Degree of Scientific/Technical Challenge (25%), and
    • Presentation (15%).

2015 Recipient – Congress Poster TDM

Tomoyuki Enokiya,  Japan

Tomoyuki Enokiya

Sponsored by

IATDMCT

 

IATDMCT
Changes in the pharmacokinetics of teicoplanin in patients with hyperglycemic hypoalbuminemia: impact of albumin glycosylation on the binding of teicoplanin to albumin
Enokiya T1, Muraki Y, Iwamoto T, Okuda M
1Mie University Hospital, Japan

Past Recipients

  • 2013 Masako Ohno, Japan
  • 2011 Hiromi Shibasaki-Hirano, Japan

2015 Recipient – Congress Poster CT

Yoriko Shimasaki, Japan

Yoriko Shimasaki

Sponsored by

IATDMCT

 

IATDMCT

 
Therapeutic drug monitoring of acetaminophen and its glucuronide in acetaminophen induced liver injury
Shimasaki Y1, Oishi C, Kagawa Y, Tanaka F, Matsumoto N, Kato R, Ijiri Y, Tanaka K, Hayashi T Osaka
1University of Pharmaceutical Sciences, Japan

Past Recipients

  • 2013 Rebecca Parker, USA
  • 2011 Ann-Sofie Ingels, Belgium